Drug Research
licensure announnced by wuxi biologics and gloria pharmaceuticals of the fully human pd-1 antibody, gls-010 , to arcus biosciences
WuXi Biologics a global leadingopen-access biologics technology platform company offering end-to-end solutions for biologicsdiscovery, development and manufacturing, and its Chinese partner Harbin Gloria PharmaceuticalsCo Ltd , today announced that an exclusive license to the anti-PD-1 antibody...
Drug Research
InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US
InDex Pharmaceuticals Holding AB announced that the US FDA has granted orphan-drug designation for the drug candidate cobitolimod for treatment of ulcerative colitis in pediatric patients. “We are pleased that the FDA has granted orphan-drug designation for...
Articles
Cancer drug screening process saves discovery time and limits use of mice
A method of testing drugs thatprompt the immune system to attack and destroy cancer cells has been developed which can speed up drug discovering andreducethe unnecessary use of mice in drug screening programmes.
Certain cancer drugs help the body’s immune...
Drug Research
Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product
Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca® Depot, at Recipharm in Solna, Sweden. The manufacturing line is dedicated to...
Drug Research
Asia Precision Medicine Research Array For Regional Screening Initiatives Announced By Thermo Fisher Scientific
Epidemiologists conducting national precision medicine initiatives focused on gathering clinical research data on genetic variation among East and South Asian populations now have access to Thermo Fisher Scientific's Applied Biosystems Axiom Asia Precision Medicine Research Array. ...
Drug Research
Abbvie and principia announce collaboration on oral immunoproteasome inhibitors
AbbVie , a global biopharmaceutical company, and Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company, announced today that they have entered a collaboration for the development of oral immunoproteasome inhibitors. The collaboration is aimed at developing...
Drug Research
Thermo Fisher Scientific and SRI International Collaborate to Enhance Small Molecule Research
Thermo Fisher Scientific Inc., the world leader in serving science, and SRI International, a research center that creates world-changing solutions, today announced the results of a collaboration agreement to enable researchers to combine the results of high-resolution Orbitrap LC/MS...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read